{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:26:29Z","timestamp":1787775989217,"version":"build-2784847793"},"reference-count":349,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["NIHR127489"],"award-info":[{"award-number":["NIHR127489"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\"><jats:title>Background<\/jats:title>\n<jats:p>Health economic assessments are used to determine whether the resources needed to generate net benefit from an antenatal or newborn screening programme, driven by multiple benefits and harms, are justifiable. It is not known what benefits and harms have been adopted by economic evaluations assessing these programmes and whether they omit benefits and harms considered important to relevant stakeholders.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-2\"><jats:title>Objectives<\/jats:title>\n<jats:p>(1) To identify the benefits and harms adopted by health economic assessments in this area, and to assess how they have been measured and valued; (2) to identify attributes or relevance to stakeholders that ought to be considered in future economic assessments; and (3) to make recommendations about the benefits and harms that should be considered by these studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-3\"><jats:title>Design<\/jats:title>\n<jats:p>Mixed methods combining systematic review and qualitative work.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-4\"><jats:title>Systematic review methods<\/jats:title>\n<jats:p>We searched the published and grey literature from January 2000 to January 2021 using all major electronic databases. Economic evaluations of an antenatal or newborn screening programme in one or more Organisation for Economic Co-operation and Development countries were considered eligible. Reporting quality was assessed using the Consolidated Health Economic Evaluation Reporting Standards checklist. We identified benefits and harms using an integrative descriptive analysis and constructed a thematic framework.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-5\"><jats:title>Qualitative methods<\/jats:title>\n<jats:p>We conducted a meta-ethnography of the existing literature on newborn screening experiences, a secondary analysis of existing individual interviews related to antenatal or newborn screening or living with screened-for conditions, and a thematic analysis of primary data collected with stakeholders about their experiences with screening.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-6\"><jats:title>Results<\/jats:title>\n<jats:p>The literature searches identified 52,244 articles and reports, and 336 unique studies were included. Thematic framework resulted in seven themes: (1) diagnosis of screened for condition, (2) life-years and health status adjustments, (3) treatment, (4) long-term costs, (5) overdiagnosis, (6) pregnancy loss and (7) spillover effects on family members. Diagnosis of screened-for condition (115, 47.5%), life-years and health status adjustments (90, 37.2%) and treatment (88, 36.4%) accounted for most of the benefits and harms evaluating antenatal screening. The same themes accounted for most of the benefits and harms included in studies assessing newborn screening. Long-term costs, overdiagnosis and spillover effects tended to be ignored. The wide-reaching family implications of screening were considered important to stakeholders. We observed good overlap between the thematic framework and the qualitative evidence.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-7\"><jats:title>Limitations<\/jats:title>\n<jats:p>Dual data extraction within the systematic literature review was not feasible due to the large number of studies included. It was difficult to recruit healthcare professionals in the stakeholder\u2019s interviews.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-8\"><jats:title>Conclusions<\/jats:title>\n<jats:p>There is no consistency in the selection of benefits and harms used in health economic assessments in this area, suggesting that additional methods guidance is needed. Our proposed thematic framework can be used to guide the development of future health economic assessments evaluating antenatal and newborn screening programmes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-9\"><jats:title>Study registration<\/jats:title>\n<jats:p>This study is registered as PROSPERO CRD42020165236.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-10\"><jats:title>Funding<\/jats:title>\n<jats:p>This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR127489) and is published in full in <jats:italic>Health Technology Assessment<\/jats:italic>; Vol. 28, No. 25. See the NIHR Funding and Awards website for further award information.<\/jats:p>\n<\/jats:sec>","DOI":"10.3310\/pytk6591","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T07:23:50Z","timestamp":1719559430000},"page":"1-180","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2233-6544","authenticated-orcid":true,"given":"Oliver","family":"Rivero-Arias","sequence":"first","affiliation":[{"name":"National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5876-9363","authenticated-orcid":true,"given":"May Ee","family":"Png","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4519-2280","authenticated-orcid":true,"given":"Ashley","family":"White","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7975-374X","authenticated-orcid":true,"given":"Miaoqing","family":"Yang","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9843-4736","authenticated-orcid":true,"given":"Sian","family":"Taylor-Phillips","sequence":"additional","affiliation":[{"name":"Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6082-3151","authenticated-orcid":true,"given":"Lisa","family":"Hinton","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3268-6276","authenticated-orcid":true,"given":"Felicity","family":"Boardman","sequence":"additional","affiliation":[{"name":"Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5041-2095","authenticated-orcid":true,"given":"Abigail","family":"McNiven","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1318-0074","authenticated-orcid":true,"given":"Jane","family":"Fisher","sequence":"additional","affiliation":[{"name":"Antenatal Results and Choices, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5531-4301","authenticated-orcid":true,"given":"Baskaran","family":"Thilaganathan","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-4912","authenticated-orcid":true,"given":"Sam","family":"Oddie","sequence":"additional","affiliation":[{"name":"Bradford Institute for Health Research, Bradford Children\u2019s Research, Bradford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3338-8457","authenticated-orcid":true,"given":"Anne-Marie","family":"Slowther","sequence":"additional","affiliation":[{"name":"Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7967-5112","authenticated-orcid":true,"given":"Svetlana","family":"Ratushnyak","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1142-6440","authenticated-orcid":true,"given":"Nia","family":"Roberts","sequence":"additional","affiliation":[{"name":"Bodleian Health Care Libraries, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-3395","authenticated-orcid":true,"given":"Jenny","family":"Shilton Osborne","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3121-6050","authenticated-orcid":true,"given":"Stavros","family":"Petrou","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2024,6]]},"reference":[{"key":"key2024062812475600_ref1-bib1","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780198805984.001.0001","volume-title":"Screening: Evidence and Practice","author":"Raffle","year":"2019"},{"key":"key2024062812475600_ref2-bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4050","article-title":"False-negative results in screening programmes: systematic review of impact and implications","volume":"4","author":"Petticrew","year":"2000","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref3-bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/pd.892","article-title":"How do women of diverse backgrounds value prenatal testing outcomes?","volume":"24","author":"Kuppermann","year":"2004","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref4-bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/pd.4808","article-title":"Preferences regarding contemporary prenatal genetic tests among women desiring testing: implications for optimal testing strategies","volume":"36","author":"Kuppermann","year":"2016","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref5-bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/AOG.0000000000001029","article-title":"Prenatal testing in the genomic age: clinical outcomes, quality of life, and costs","volume":"126","author":"Kaimal","year":"2015","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref6-bib6","doi-asserted-by":"crossref","first-page":"e004862","DOI":"10.1161\/JAHA.116.004862","article-title":"Mental health among parents of children with critical congenital heart defects: a systematic review","volume":"6","author":"Woolf-King","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"key2024062812475600_ref7-bib7","doi-asserted-by":"crossref","first-page":"e2020028571","DOI":"10.1542\/peds.2020-028571","article-title":"Mortality among parents of children with major congenital anomalies","volume":"147","author":"Fuller","year":"2021","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref8-bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/uog.1854","article-title":"Psychological outcome in women undergoing termination of pregnancy for ultrasound-detected fetal anomaly in the first and second trimesters: a pilot study","volume":"25","author":"Davies","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key2024062812475600_ref9-bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pd.1127","article-title":"Long-term psychological consequences of pregnancy termination for fetal abnormality: a cross-sectional study","volume":"25","author":"Korenromp","year":"2005","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref10-bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12920-017-0247-4","article-title":"Genomic newborn screening: public health policy considerations and recommendations","volume":"10","author":"Friedman","year":"2017","journal-title":"BMC Med Genomics"},{"key":"key2024062812475600_ref11-bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jval.2018.06.017","article-title":"Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions","volume":"21","author":"Phillips","year":"2018","journal-title":"Value Health"},{"key":"key2024062812475600_ref12-bib12","volume-title":"UK NSC: Evidence Review Process","author":"Public Health England"},{"key":"key2024062812475600_ref13-bib13","first-page":"1","article-title":"Screening for type 2 diabetes: a short report for the National Screening Committee","volume":"35","author":"Waugh","year":"2013","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref14-bib14","volume-title":"Guide to the Methods of Technology Appraisal 2013","author":"National Institute for Health and Care Excellence"},{"key":"key2024062812475600_ref15-bib15","volume-title":"Guidance to Manufacturers for Completion of New Product Assessment Form","author":"Scottish Medicines Consortium"},{"key":"key2024062812475600_ref16-bib16","volume-title":"Choices in Methods for Economic Evaluation","author":"Haute Autorit\u00e9 de Sant\u00e9"},{"key":"key2024062812475600_ref17-bib17","volume-title":"Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC)","author":"Australian Government Department of Health"},{"key":"key2024062812475600_ref18-bib18","volume-title":"Guidelines for the Economic Evaluation of Health Technologies: Canada","author":"Canadian Agency for Drugs and Technologies in Health (CADTH)"},{"key":"key2024062812475600_ref19-bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice of decision analytic modeling in health care evaluation: report of the ISPOR Task Force on Good Research Practices-Modeling Studies","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"key":"key2024062812475600_ref20-bib20","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta11520","article-title":"A review and critique of modelling in prioritising and designing screening programmes","volume":"11","author":"Karnon","year":"2007","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref21-bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.1375","article-title":"The valuation of prenatal life in economic evaluations of perinatal interventions","volume":"18","author":"Simon","year":"2009","journal-title":"Health Econ"},{"key":"key2024062812475600_ref22-bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/hec.636","article-title":"Methodological limitations of economic evaluations of antenatal screening","volume":"10","author":"Petrou","year":"2001","journal-title":"Health Econ"},{"key":"key2024062812475600_ref23-bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0272989X17732990","article-title":"A systematic review and meta-analysis of childhood health utilities","volume":"38","author":"Kwon","year":"2018","journal-title":"Med Decis Making"},{"key":"key2024062812475600_ref24-bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0272989X15605094","article-title":"A framework for including family health spillovers in economic evaluation","volume":"36","author":"Al-Janabi","year":"2016","journal-title":"Med Decis Making"},{"key":"key2024062812475600_ref25-bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jval.2016.11.007","article-title":"Eliciting preferences for information provision in newborn bloodspot screening programs","volume":"20","author":"Wright","year":"2017","journal-title":"Value Health"},{"key":"key2024062812475600_ref26-bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pd.4571","article-title":"Women\u2019s and healthcare professionals\u2019 preferences for prenatal testing: a discrete choice experiment","volume":"35","author":"Beulen","year":"2015","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref27-bib27","volume-title":"Non-invasive Prenatal Testing: Ethical Issues","author":"Nuffield Council on Bioethics"},{"key":"key2024062812475600_ref28-bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000314644","article-title":"Parental attitudes toward ethical and social issues surrounding the expansion of newborn screening using new technologies","volume":"14","author":"Hasegawa","year":"2011","journal-title":"Public Health Genomics"},{"key":"key2024062812475600_ref29-bib29","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/hex.12159","article-title":"Will the introduction of non-invasive prenatal testing for Down\u2019s syndrome undermine informed choice?","volume":"18","author":"Silcock","year":"2015","journal-title":"Health Expect"},{"key":"key2024062812475600_ref30-bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/ijns6040094","article-title":"The methodological quality and challenges in conducting economic evaluations of newborn screening: a scoping review","volume":"6","author":"Cacciatore","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"key2024062812475600_ref31-bib31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1472-6963-12-300","article-title":"Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening","volume":"12","author":"Langer","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"key2024062812475600_ref32-bib32","volume-title":"The Listening Series: Including Everyone in Public Engagement with Research. Guidance for Researchers","author":"McMillan"},{"key":"key2024062812475600_ref33-bib33","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1136\/bmj.j3453","article-title":"GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research","volume":"358","author":"Staniszewska","year":"2017","journal-title":"BMJ"},{"key":"key2024062812475600_ref34-bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.rbmo.2013.06.008","article-title":"Mapping men\u2019s anticipations and experiences in the reproductive realm: (in)fertility journeys","volume":"27","author":"Hinton","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"key2024062812475600_ref35-bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3399\/bjgp08X277276","article-title":"Parents\u2019 experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era","volume":"58","author":"Locock","year":"2008","journal-title":"Br J Gen Pract"},{"key":"key2024062812475600_ref36-bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.socscimed.2014.02.025","article-title":"The expressivist objection to prenatal testing: the experiences of families living with genetic disease","volume":"107","author":"Boardman","year":"2014","journal-title":"Soc Sci Med"},{"key":"key2024062812475600_ref37-bib37","volume-title":"Antenatal Screening Standards: Data Report 1 April 2018 to 31 March 2019","author":"Public Health England"},{"key":"key2024062812475600_ref38-bib38","doi-asserted-by":"crossref","first-page":"e048031","DOI":"10.1136\/bmjopen-2020-048031","article-title":"Methods for evaluating the benefits and harms of antenatal and newborn screening programmes adopted by health economic assessments: protocol for a systematic review","volume":"11","author":"Png","year":"2021","journal-title":"BMJ Open"},{"key":"key2024062812475600_ref39-bib39","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"key2024062812475600_ref40-bib40","volume-title":"List of OECD Member Countries \u2013 Ratification of the Convention on the OECD","author":"Organisation for Economic Co-operation and Development (OECD)"},{"key":"key2024062812475600_ref41-bib41","doi-asserted-by":"crossref","first-page":"k1612","DOI":"10.1136\/bmj.k1612","article-title":"Association between use of systematic reviews and national policy recommendations on screening newborn babies for rare diseases: systematic review and meta-analysis","volume":"361","author":"Taylor-Phillips","year":"2018","journal-title":"BMJ"},{"key":"key2024062812475600_ref42-bib42","author":"Canadian Agency for Drugs and Technologies in Health (CADTH) (2011)"},{"key":"key2024062812475600_ref45-bib45","doi-asserted-by":"crossref","first-page":"f1049","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"key":"key2024062812475600_ref46-bib46","doi-asserted-by":"crossref","first-page":"e067975","DOI":"10.1136\/bmj-2021-067975","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"376","author":"Husereau","year":"2022","journal-title":"BMJ"},{"key":"key2024062812475600_ref47-bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/1049732308314930","article-title":"Confusing categories and themes","volume":"18","author":"Morse","year":"2008","journal-title":"Qual Health Res"},{"key":"key2024062812475600_ref48-bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/nur.20362","article-title":"What\u2019s in a name? Qualitative description revisited","volume":"33","author":"Sandelowski","year":"2010","journal-title":"Res Nurs Health"},{"key":"key2024062812475600_ref49-bib49","doi-asserted-by":"crossref","first-page":"114367","DOI":"10.1016\/j.socscimed.2021.114367","article-title":"Absorbing it all: a meta-ethnography of parents\u2019 unfolding experiences of newborn screening","volume":"287","author":"White","year":"2021","journal-title":"Soc Sci Med"},{"key":"key2024062812475600_ref50-bib50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/medu.12092","article-title":"Qualitative synthesis and systematic review in health professions education","volume":"47","author":"Bearman","year":"2013","journal-title":"Med Educ"},{"key":"key2024062812475600_ref51-bib51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ogrm.2020.10.005","article-title":"Fetal anomaly screening programme","volume":"30","author":"Alt","year":"2020","journal-title":"Obstet Gynaecol Reprod Med"},{"key":"key2024062812475600_ref52-bib52","doi-asserted-by":"crossref","first-page":"114367","DOI":"10.1016\/j.socscimed.2021.114367","article-title":"Absorbing it all: a meta-ethnography of parents\u2019 unfolding experiences of newborn screening","volume":"287","author":"White","year":"2021","journal-title":"Soc Sci Med"},{"key":"key2024062812475600_ref53-bib53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2524.2011.01036.x","article-title":"A systematic review of issues around antenatal screening and prenatal diagnostic testing for genetic disorders: women of Asian origin in western countries","volume":"20","author":"Yu","year":"2012","journal-title":"Health Soc Care Community"},{"key":"key2024062812475600_ref54-bib54","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0968-8080(14)44799-2","article-title":"Termination of pregnancy for fetal abnormality: a meta-ethnography of women\u2019s experiences","volume":"22","author":"Lafarge","year":"2014","journal-title":"Reprod Health Matters"},{"key":"key2024062812475600_ref55-bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijnurstu.2012.05.004","article-title":"Men\u2019s experiences of antenatal screening: a metasynthesis of the qualitative research","volume":"50","author":"Dheensa","year":"2013","journal-title":"Int J Nurs Stud"},{"key":"key2024062812475600_ref56-bib56","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.socscimed.2009.09.006","article-title":"A meta-synthesis of pregnant women\u2019s decision-making processes with regard to antenatal screening for Down syndrome","volume":"69","author":"Reid","year":"2009","journal-title":"Soc Sci Med"},{"key":"key2024062812475600_ref57-bib57","doi-asserted-by":"crossref","first-page":"e0261096","DOI":"10.1371\/journal.pone.0261096","article-title":"First and second trimester ultrasound in pregnancy: a systematic review and metasynthesis of the views and experiences of pregnant women, partners, and health workers","volume":"16","author":"Moncrieff","year":"2021","journal-title":"PLOS ONE"},{"key":"key2024062812475600_ref58-bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/sono.12213","article-title":"Delivering unexpected news via obstetric ultrasound: a systematic review and meta-ethnographic synthesis of expectant parent and staff experiences","volume":"7","author":"Johnson","year":"2020","journal-title":"Sonography"},{"key":"key2024062812475600_ref59-bib59","volume-title":"Genomics England","author":"Genomics England"},{"key":"key2024062812475600_ref60-bib60","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/1049732303253462","article-title":"Metasynthesis: the state of the art \u2013 so far","volume":"13","author":"Finfgeld","year":"2003","journal-title":"Qual Health Res"},{"key":"key2024062812475600_ref61-bib61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1053815111425493","article-title":"Understanding qualitative metasynthesis: issues and opportunities in early childhood intervention research","volume":"33","author":"Erwin","year":"2011","journal-title":"J Early Interv"},{"key":"key2024062812475600_ref62-bib62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2288-9-59","article-title":"Methods for the synthesis of qualitative research: a critical review","volume":"9","author":"Barnett-Page","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"key2024062812475600_ref63-bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-80","article-title":"Meta-ethnography 25 years on: challenges and insights for synthesising a large number of qualitative studies","volume":"14","author":"Toye","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"key2024062812475600_ref64-bib64","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1049732315576493","article-title":"Using Sandelowski and Barroso\u2019s meta-synthesis method in advancing qualitative evidence","volume":"26","author":"Ludvigsen","year":"2016","journal-title":"Qual Health Res"},{"key":"key2024062812475600_ref65-bib65","volume-title":"Newborn Blood Spot Screening: Programme Handbook","author":"Public Health England"},{"key":"key2024062812475600_ref66-bib66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/medethics-2011-100040","article-title":"Proceduralisation, choice and parental reflections on decisions to accept newborn bloodspot screening","volume":"38","author":"Nicholls","year":"2012","journal-title":"J Med Ethics"},{"key":"key2024062812475600_ref67-bib67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/phe\/phq016","article-title":"Knowledge or understanding? Informed choice in the context of newborn bloodspot screening","volume":"3","author":"Nicholls","year":"2010","journal-title":"Public Health Ethics"},{"key":"key2024062812475600_ref68-bib68","doi-asserted-by":"crossref","first-page":"e79441","DOI":"10.1371\/journal.pone.0079441","article-title":"Parental decision-making and acceptance of newborn bloodspot screening: an exploratory study","volume":"8","author":"Nicholls","year":"2013","journal-title":"PLOS ONE"},{"key":"key2024062812475600_ref69-bib69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.midw.2006.05.008","article-title":"Mothers\u2019 accounts of screening newborn babies in Wales (UK)","volume":"23","author":"Parsons","year":"2007","journal-title":"Midwifery"},{"key":"key2024062812475600_ref70-bib70","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10897-016-9959-4","article-title":"Parents\u2019 experiences of receiving the initial positive newborn screening (NBS) result for cystic fibrosis and sickle cell disease","volume":"25","author":"Chudleigh","year":"2016","journal-title":"J Genet Couns"},{"key":"key2024062812475600_ref71-bib71","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.socscimed.2011.06.062","article-title":"Newborn screening and maternal diagnosis: rethinking family benefit","volume":"73","author":"Buchbinder","year":"2011","journal-title":"Soc Sci Med"},{"key":"key2024062812475600_ref72-bib72","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0009922812446011","article-title":"Newborn screening for metabolic disorders: parental perceptions of the initial communication of results","volume":"51","author":"Buchbinder","year":"2012","journal-title":"Clin Pediatr (Phila)"},{"key":"key2024062812475600_ref73-bib73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/14636770600855218","article-title":"Parenting in the genomic age: the \u2018cursed blessing\u2019 of newborn screening","volume":"25","author":"Grob","year":"2006","journal-title":"New Genet Soc"},{"key":"key2024062812475600_ref74-bib74","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/0022146510386794","article-title":"Patients-in-waiting: living between sickness and health in the genomics era","volume":"51","author":"Timmermans","year":"2010","journal-title":"J Health Soc Behav"},{"key":"key2024062812475600_ref75-bib75","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ejhg.2014.126","article-title":"Parents\u2019 responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening","volume":"23","author":"Ulph","year":"2015","journal-title":"Eur J Human Genet"},{"key":"key2024062812475600_ref76-bib76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1442-2018.2006.00272_9.x","article-title":"Psychosocial issues associated with genetic testing in cystic fibrosis newborn screening","volume":"8","author":"Tluczek","year":"2006","journal-title":"Nurs Health Sci"},{"key":"key2024062812475600_ref77-bib77","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.socscimed.2008.06.003","article-title":"Is my sick child healthy? Is my healthy child sick?: changing parental experiences of cystic fibrosis in the age of expanded newborn screening","volume":"67","author":"Grob","year":"2008","journal-title":"Soc Sci Med"},{"key":"key2024062812475600_ref78-bib78","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2307\/2393553","article-title":"Absorptive capacity: a new perspective on learning and innovation","volume":"35","author":"Cohen","year":"1990","journal-title":"Adm Sci Q"},{"key":"key2024062812475600_ref79-bib79","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jcf.2006.09.001","article-title":"Newborn screening for CF in a regional paediatric centre: the psychosocial effects of false-positive IRT results on parents","volume":"6","author":"Moran","year":"2007","journal-title":"J Cyst Fibrosis"},{"key":"key2024062812475600_ref80-bib80","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1367493512443906","article-title":"Informing parents about positive newborn screen results: parents\u2019 recommendations","volume":"16","author":"Salm","year":"2012","journal-title":"J Child Health Care"},{"key":"key2024062812475600_ref81-bib81","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/ijns5040042","article-title":"Family perspectives on newborn screening for X-linked adrenoleukodystrophy in California","volume":"5","author":"Schwan","year":"2019","journal-title":"Int J Neonatal Screen"},{"key":"key2024062812475600_ref82-bib82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1049732309356285","article-title":"When the cystic fibrosis label does not fit: a modified uncertainty theory","volume":"20","author":"Tluczek","year":"2010","journal-title":"Qual Health Res"},{"key":"key2024062812475600_ref83-bib83","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.pedn.2014.01.007","article-title":"It was an overwhelming thing\u2019: parents\u2019 needs after infant diagnosis with congenital adrenal hyperplasia","volume":"29","author":"Boyse","year":"2014","journal-title":"J Pediatr Nurs"},{"key":"key2024062812475600_ref84-bib84","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3399\/bjgp08X277276","article-title":"Parents\u2019 experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era","volume":"58","author":"Locock","year":"2008","journal-title":"Br J Gen Pract"},{"key":"key2024062812475600_ref85-bib85","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/JPN.0b013e3181a1bc1f","article-title":"Newborn screening: an appeal for improved parent education","volume":"23","author":"Tluczek","year":"2009","journal-title":"J Perinat Neonatal Nurs"},{"key":"key2024062812475600_ref86-bib86","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s10897-018-0227-7","article-title":"Parenting a Child with Phenylketonuria (PKU): an Interpretative Phenomenological Analysis (IPA) of the experience of parents","volume":"27","author":"Carpenter","year":"2018","journal-title":"J Genet Couns"},{"key":"key2024062812475600_ref87-bib87","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1179\/1753807615Y.0000000007","article-title":"Internet searching after parents receive abnormal newborn screening results","volume":"8","author":"Patterson","year":"2015","journal-title":"J Commun Healthc"},{"key":"key2024062812475600_ref88-bib88","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/14636778.2018.1451315","article-title":"Parents like me: biosociality and lay expertise in self-help groups of parents of screen-positive newborns","volume":"37","author":"Raz","year":"2018","journal-title":"New Genet Soc"},{"key":"key2024062812475600_ref89-bib89","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10545-018-0159-2","article-title":"Newborn screening for Pompe disease: impact on families","volume":"41","author":"Pruniski","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"key2024062812475600_ref90-bib90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ijns5020023","article-title":"Psychological impact on parents of an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis: a qualitative study","volume":"5","author":"Johnson","year":"2019","journal-title":"Int J Neonatal Screen"},{"key":"key2024062812475600_ref91-bib91","doi-asserted-by":"crossref","first-page":"204","DOI":"10.52964\/AMJA.0865","article-title":"Communicating diagnostic uncertainty in the acute and emergency medical setting: a systematic review and ethical analysis of the empirical literature","volume":"20","author":"Hart","year":"2021","journal-title":"Acute Med"},{"key":"key2024062812475600_ref92-bib92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.2010-3413","article-title":"Parents\u2019 experiences of expanded newborn screening evaluations","volume":"128","author":"DeLuca","year":"2011","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref93-bib93","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10897-006-9031-x","article-title":"Newborn screening for cystic fibrosis: parents\u2019 preferences regarding counseling at the time of infants\u2019 sweat test","volume":"15","author":"Tluczek","year":"2006","journal-title":"J Genet Couns"},{"key":"key2024062812475600_ref94-bib94","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1049732310382919","article-title":"Psychosocial consequences of false-positive newborn screens for cystic fibrosis","volume":"21","author":"Tluczek","year":"2011","journal-title":"Qual Health Res"},{"key":"key2024062812475600_ref95-bib95","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/01459740.2010.531065","article-title":"Medical technologies and the dream of the perfect newborn","volume":"30","author":"Buchbinder","year":"2011","journal-title":"Med Anthropol"},{"key":"key2024062812475600_ref96-bib96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12687-018-0361-9","article-title":"Coming to terms with the imperfectly normal child: attitudes of Israeli parents of screen-positive infants regarding subsequent prenatal diagnosis","volume":"10","author":"Raz","year":"2019","journal-title":"J Community Genet"},{"key":"key2024062812475600_ref97-bib97","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10897-013-9675-2","article-title":"Informing children of their newborn screening carrier result for sickle cell or cystic fibrosis: qualitative study of parents\u2019 intentions, views and support needs","volume":"23","author":"Ulph","year":"2014","journal-title":"J Genet Couns"},{"key":"key2024062812475600_ref98-bib98","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1002\/hast.1019","article-title":"Qualitative research on expanded prenatal and newborn screening: robust but marginalized","volume":"49","author":"Grob","year":"2019","journal-title":"Hastings Cent Rep"},{"key":"key2024062812475600_ref99-bib99","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1525\/si.2003.26.4.553","article-title":"Situational analyses: grounded theory mapping after the postmodern turn","volume":"26","author":"Clarke","year":"2003","journal-title":"Symb Interact"},{"key":"key2024062812475600_ref100-bib100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1037\/cou0000527","article-title":"The shape of knowledge: situational analysis in counseling psychology research","volume":"68","author":"Grzanka","year":"2021","journal-title":"J Couns Psychol"},{"key":"key2024062812475600_ref101-bib101","volume-title":"The Coding Manual for Qualitative Researchers","author":"Saldana","year":"2016"},{"key":"key2024062812475600_ref102-bib102","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/bmj.320.7227.114","article-title":"Qualitative research in health care: analysing qualitative data","volume":"320","author":"Pope","year":"2000","journal-title":"BMJ"},{"key":"key2024062812475600_ref103-bib103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2929.2006.02467.x","article-title":"Making sense of qualitative data analysis: an introduction with illustrations from DIPEx (personal experiences of health and illness)","volume":"40","author":"Ziebland","year":"2006","journal-title":"Med Educ"},{"key":"key2024062812475600_ref104-bib104","doi-asserted-by":"crossref","DOI":"10.3310\/hta5050","article-title":"Eliciting public preferences for healthcare: a systematic review of techniques","volume":"5","author":"Ryan","year":"2001","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref105-bib105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.socscimed.2014.01.013","article-title":"Valuing patients\u2019 experiences of healthcare processes: towards broader applications of existing methods","volume":"106","author":"Ryan","year":"2014","journal-title":"Soc Sci Med"},{"key":"key2024062812475600_ref106-bib106","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/hec.1086","article-title":"Is there a case for using visual analogue scale valuations in cost\u2013utility analysis?","volume":"15","author":"Parkin","year":"2006","journal-title":"Health Econ"},{"key":"key2024062812475600_ref107-bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12884-019-2278-7","article-title":"Preferences for aspects of antenatal and newborn screening: a systematic review","volume":"19","author":"Vass","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"key2024062812475600_ref108-bib108","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40273-021-01128-0","article-title":"Systematic review of conceptual, age, measurement and valuation considerations for generic multidimensional childhood patient-reported outcome measures","volume":"40","author":"Kwon","year":"2022","journal-title":"Pharmacoeconomics"},{"key":"key2024062812475600_ref109-bib109","doi-asserted-by":"crossref","first-page":"e0203276","DOI":"10.1371\/journal.pone.0203276","article-title":"A descriptive system for the Infant health-related Quality of life Instrument (IQI): measuring health with a mobile app","volume":"13","author":"Jabrayilov","year":"2018","journal-title":"PLOS ONE"},{"key":"key2024062812475600_ref110-bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-020-1271-1","article-title":"Item generation for a proxy health related quality of life measure in very young children","volume":"18","author":"Verstraete","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"key2024062812475600_ref111-bib111","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hec.4730040602","article-title":"Willingness to pay for antenatal carrier screening for cystic fibrosis","volume":"4","author":"Donaldson","year":"1995","journal-title":"Health Econ"},{"key":"key2024062812475600_ref112-bib112","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pediatrneurol.2016.09.008","article-title":"Willingness to pay for a newborn screening test for spinal muscular atrophy","volume":"66","author":"Lin","year":"2017","journal-title":"Pediatr Neurol"},{"key":"key2024062812475600_ref113-bib113","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1067\/mob.2000.105967","article-title":"An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes","volume":"183","author":"Rouse","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref114-bib114","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1067\/mob.2000.103943","article-title":"Routine second-trimester ultrasonography in the United States: a cost\u2013benefit analysis","volume":"182","author":"Vintzileos","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref115-bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7110","article-title":"First and second trimester antenatal screening for Down syndrome: the results of the serum, urine and ultrasound screening study (SURUSS)","volume":"7","author":"Wald","year":"2003","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref116-bib116","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/pd.4511","article-title":"A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome","volume":"35","author":"Walker","year":"2015","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref117-bib117","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1186\/s12889-019-8110-5","article-title":"The cost-effectiveness of screening tools used in the diagnosis of fetal alcohol spectrum disorder: a modelled analysis","volume":"19","author":"Berrigan","year":"2019","journal-title":"BMC Public Health"},{"key":"key2024062812475600_ref118-bib118","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/AOG.0000000000000224","article-title":"Cost\u2013benefit analysis of indirect antiglobulin screening in Rh(D)-negative women at 28 weeks of gestation","volume":"123","author":"Abbey","year":"2014","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref119-bib119","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/AOG.0000000000000997","article-title":"Third-trimester prenatal syphilis screening: a cost-effectiveness analysis","volume":"126","author":"Albright","year":"2015","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref120-bib120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00126334-200012150-00004","article-title":"The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States","volume":"25","author":"Zaric","year":"2000","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"key2024062812475600_ref121-bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13420","article-title":"Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness","volume":"13","author":"Daniels","year":"2009","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref122-bib122","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.ajog.2005.07.001","article-title":"Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis","volume":"193","author":"Doyle","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref123-bib123","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1701-2163(15)30864-1","article-title":"Cost-effectiveness of the management of Rh-negative pregnant women","volume":"35","author":"Duplantie","year":"2013","journal-title":"J Obstet Gynaecol Canada"},{"key":"key2024062812475600_ref124-bib124","first-page":"256","article-title":"A comparison of three screening strategies for prevention of perinatal HIV infection in Colombia: a decision analysis model","volume":"24","author":"Gomez","year":"2008","journal-title":"Pan Am J Public Health"},{"key":"key2024062812475600_ref125-bib125","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1542\/peds.105.4.e54","article-title":"Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago","volume":"105","author":"Immergluck","year":"2000","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref126-bib126","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1034\/j.1600-0412.2002.810713.x","article-title":"Symptom-free women at increased risk of ectopic pregnancy: should we screen?","volume":"81","author":"Mol","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key2024062812475600_ref127-bib127","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/uog.19076","article-title":"Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia","volume":"53","author":"Ortved","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key2024062812475600_ref128-bib128","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.vaccine.2005.09.028","article-title":"The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles","volume":"24","author":"Pinot","year":"2006","journal-title":"Vaccine"},{"key":"key2024062812475600_ref129-bib129","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0301-2115(02)00042-8","article-title":"Cost-effectiveness analysis of gestational diabetes mellitus screening in France","volume":"103","author":"Poncet","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key2024062812475600_ref130-bib130","first-page":"243","article-title":"Voluntary screening program for HIV in pregnancy. Cost effectiveness","volume":"46","author":"Rivera-Alsina","year":"2001","journal-title":"J Reprod Med"},{"key":"key2024062812475600_ref131-bib131","first-page":"840","article-title":"Choosing a strategy to prevent neonatal early-onset group B streptococcal sepsis: economic evaluation","volume":"108","author":"Stan","year":"2001","journal-title":"BJOG"},{"key":"key2024062812475600_ref132-bib132","doi-asserted-by":"crossref","first-page":"e1002778","DOI":"10.1371\/journal.pmed.1002778","article-title":"Screening for breech presentation using universal late-pregnancy ultrasonography: a prospective cohort study and cost effectiveness analysis","volume":"16","author":"Wastlund","year":"2019","journal-title":"PLOS Med"},{"key":"key2024062812475600_ref133-bib133","first-page":"10","article-title":"Cost effectiveness of latest recommendations for group B streptococci screening in the United States","volume":"10","author":"Williams","year":"2020","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref134-bib134","first-page":"782","article-title":"Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission","volume":"102","author":"Sansom","year":"2003","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref135-bib135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0272989X03261570","article-title":"Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care","volume":"24","author":"Mrus","year":"2004","journal-title":"Med Decis Making"},{"key":"key2024062812475600_ref136-bib136","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/uog.22193","article-title":"Cost effectiveness analysis of a model of first trimester prediction and prevention for preterm preeclampsia against usual care","volume":"58","author":"Park","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key2024062812475600_ref137-bib137","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2214-109X(20)30395-8","article-title":"Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study","volume":"9","author":"Rodriguez","year":"2021","journal-title":"Lancet Glob Health"},{"key":"key2024062812475600_ref138-bib138","volume-title":"Rhesus typing av foster basert p\u00e5 blodpr\u00f8ve fra rhesus negative gravide","author":"Arentz-Hansen"},{"key":"key2024062812475600_ref139-bib139","volume-title":"Repeat Screening for Syphilis in Pregnancy as an Alternative Screening Strategy in the UK: A Cost-effectiveness Analysis","author":"Huntington"},{"key":"key2024062812475600_ref140-bib140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/21678707.2016.1179572","article-title":"Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain","volume":"4","author":"Castilla-Rodriguez","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"key":"key2024062812475600_ref141-bib141","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1542\/peds.2005-2782","article-title":"Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis","volume":"118","author":"van den Akker-van Marle","year":"2006","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref142-bib142","doi-asserted-by":"crossref","first-page":"e0132313","DOI":"10.1371\/journal.pone.0132313","article-title":"An economic analysis of cell-free DNA non-invasive prenatal testing in the US general pregnancy population","volume":"10","author":"Benn","year":"2015","journal-title":"PLOS ONE"},{"key":"key2024062812475600_ref143-bib143","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2014.08.028","article-title":"The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis","volume":"182","author":"Beulen","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key2024062812475600_ref144-bib144","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajog.2003.09.028","article-title":"An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years","volume":"190","author":"Biggio","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref145-bib145","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00002030-200303280-00013","article-title":"The cost effectiveness of universal antenatal screening for HIV in New Zealand","volume":"17","author":"Bramley","year":"2003","journal-title":"AIDS"},{"key":"key2024062812475600_ref146-bib146","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/pd.336","article-title":"An increase in cost-effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing","volume":"22","author":"Christiansen","year":"2002","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref147-bib147","first-page":"18","article-title":"The cost-effectiveness of prenatal congenital heart defect screening methods in IVF pregnancies","volume":"18","author":"Chung","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key2024062812475600_ref148-bib148","first-page":"39","article-title":"Cost effectiveness, the economic considerations of prenatal screening strategies for trisomy 21 in the Czech Republic","volume":"77","author":"Dhaifalah","year":"2012","journal-title":"Ceska Gynekol"},{"key":"key2024062812475600_ref149-bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14200","article-title":"Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial","volume":"14","author":"Dormandy","year":"2010","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref150-bib150","doi-asserted-by":"crossref","first-page":"175.e1","DOI":"10.1016\/j.ajog.2010.09.017","article-title":"Cost-effectiveness and accuracy of prenatal Down syndrome screening strategies: should the combined test continue to be widely used?","volume":"204","author":"Gekas","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref151-bib151","doi-asserted-by":"crossref","first-page":"b138","DOI":"10.1136\/bmj.b138","article-title":"Comparison of different strategies in prenatal screening for Down\u2019s syndrome: cost effectiveness analysis of computer simulation","volume":"338","author":"Gekas","year":"2009","journal-title":"BMJ"},{"key":"key2024062812475600_ref152-bib152","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bmj.323.7310.423","article-title":"Screening for Down\u2019s syndrome: effects, safety, and cost effectiveness of first and second trimester strategies","volume":"323","author":"Gilbert","year":"2001","journal-title":"BMJ"},{"key":"key2024062812475600_ref153-bib153","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/421247","article-title":"Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia","volume":"190","author":"Graves","year":"2004","journal-title":"J Infect Dis"},{"key":"key2024062812475600_ref154-bib154","first-page":"S95","article-title":"Role of sequential genetic sonogram and cellfree fetal DNA after EIF detection: a cost-effectiveness analysis","volume":"216","author":"Hacker","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref155-bib155","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.ajog.2014.10.364","article-title":"Role of genetic sonogram and NIPT after EIF detection: a cost-effectiveness analysis","volume":"212","author":"Hacker","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref156-bib156","doi-asserted-by":"crossref","first-page":"116S","DOI":"10.1097\/01.AOG.0000463724.42020.71","article-title":"Role of genetic ultrasonogram after choroid plexus cyst detection a cost-effectiveness analysis","volume":"125","author":"Hacker","year":"2015","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref157-bib157","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1017\/S0266462304001369","article-title":"The cost effectiveness of prenatal ultrasound screening for trisomy 21","volume":"20","author":"Harris","year":"2004","journal-title":"Int J Technol Assess Health Care"},{"key":"key2024062812475600_ref158-bib158","first-page":"1","article-title":"Noninvasive prenatal testing for trisomies 21, 18, and 13, sex chromosome aneuploidies, and microdeletions: a Health Technology Assessment","volume":"19","author":"Health Quality Ontario","year":"2019","journal-title":"Ont Health Technol Assess Ser"},{"key":"key2024062812475600_ref159-bib159","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcf.2012.02.007","article-title":"Cost-effectiveness of carrier screening for cystic fibrosis in Australia","volume":"11","author":"Norman","year":"2012","journal-title":"J Cyst Fibrosis"},{"key":"key2024062812475600_ref160-bib160","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.AOG.0000174581.24338.6f","article-title":"A cost-effectiveness analysis of prenatal screening strategies for Down syndrome","volume":"106","author":"Odibo","year":"2005","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref161-bib161","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.qai.0000146598.40301.e6","article-title":"Cost-effectiveness of HIV screening for incarcerated pregnant women","volume":"38","author":"Resch","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key2024062812475600_ref162-bib162","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1471-0528.2005.00560.x","article-title":"Economic modelling of antenatal screening and ultrasound scanning programmes for identification of fetal abnormalities","volume":"112","author":"Ritchie","year":"2005","journal-title":"BJOG"},{"key":"key2024062812475600_ref163-bib163","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2334-8-174","article-title":"Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants","volume":"8","author":"Udeh","year":"2008","journal-title":"BMC Infect Dis"},{"key":"key2024062812475600_ref164-bib164","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/uog.1762","article-title":"Economic evaluation of ultrasound screening options for structural fetal malformations","volume":"24","author":"Vanara","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key2024062812475600_ref165-bib165","first-page":"577","article-title":"Cost\u2013benefit analysis of prenatal diagnosis for Down syndrome using the British or the American approach","volume":"95","author":"Vintzileos","year":"2000","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref166-bib166","first-page":"31","article-title":"Noninvasive prenatal testing for trisomies 21, 18, and 13, sex chromosome aneuploidies, and microdeletions in average-risk pregnancies: a cost-effectiveness analysis","volume":"31","author":"Xie","year":"2020","journal-title":"J Obstet Gynaecol Canada"},{"key":"key2024062812475600_ref167-bib167","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/hec.652","article-title":"Prenatal screening for cystic fibrosis: an economic analysis","volume":"11","author":"Nielsen","year":"2002","journal-title":"Health Econ"},{"key":"key2024062812475600_ref168-bib168","volume-title":"Testing for Hereditary Mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene","author":"Kessels"},{"key":"key2024062812475600_ref169-bib169","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/ajo.12223","article-title":"A cost-effectiveness analysis comparing different strategies to implement noninvasive prenatal testing into a Down syndrome screening program","volume":"54","author":"Ayres","year":"2014","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"key2024062812475600_ref170-bib170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12962-019-0173-8","article-title":"The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis","volume":"17","author":"Bayon","year":"2019","journal-title":"Cost Eff Resour Alloc"},{"key":"key2024062812475600_ref171-bib171","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta4160","article-title":"Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women\u2019s views","volume":"4","author":"Bricker","year":"2000","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref172-bib172","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1067\/mob.2002.127144","article-title":"Nuchal translucency and first trimester biochemical markers for Down syndrome screening: a cost-effectiveness analysis","volume":"187","author":"Caughey","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref173-bib173","doi-asserted-by":"crossref","first-page":"5","DOI":"10.7863\/jum.2002.21.1.5","article-title":"Genetic sonography: a cost-effective method for evaluating women 35 years and older who decline genetic amniocentesis","volume":"21","author":"DeVore","year":"2002","journal-title":"J Ultrasound Med"},{"key":"key2024062812475600_ref174-bib174","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s005920200016","article-title":"Universal screening and intensive metabolic management of gestational diabetes: cost-effectiveness in Italy","volume":"39","author":"Di Cianni","year":"2002","journal-title":"Acta Diabetol"},{"key":"key2024062812475600_ref175-bib175","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3109\/14767058.2015.1038703","article-title":"Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis","volume":"29","author":"Fairbrother","year":"2016","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"key2024062812475600_ref176-bib176","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejhg.2010.138","article-title":"Rapid testing versus karyotyping in Down\u2019s syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities","volume":"19","author":"Gekas","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"key2024062812475600_ref177-bib177","author":"Juvet","year":"2016"},{"key":"key2024062812475600_ref178-bib178","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jogc.2017.05.015","article-title":"Cell-free DNA-based non-invasive prenatal screening for common aneuploidies in a Canadian province: a cost-effectiveness analysis","volume":"40","author":"Nshimyumukiza","year":"2018","journal-title":"J Obstet Gynaecol Canada"},{"key":"key2024062812475600_ref179-bib179","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/pd.4156","article-title":"The role of noninvasive prenatal testing as a diagnostic versus a screening tool \u2013 a cost-effectiveness analysis","volume":"33","author":"Ohno","year":"2013","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref180-bib180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/ajo.12136","article-title":"Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies","volume":"53","author":"O\u2019Leary","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"key2024062812475600_ref181-bib181","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/1471-0528.13567","article-title":"Chlamydia screening for pregnant women aged 16\u201325 years attending an antenatal service: a cost-effectiveness study","volume":"123","author":"Ong","year":"2016","journal-title":"BJOG"},{"key":"key2024062812475600_ref182-bib182","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/uog.13287","article-title":"Cost-effectiveness of prenatal screening strategies for congenital heart disease","volume":"44","author":"Pinto","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key2024062812475600_ref183-bib183","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3109\/14767058.2013.770464","article-title":"Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population","volume":"26","author":"Song","year":"2013","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"key2024062812475600_ref184-bib184","doi-asserted-by":"crossref","first-page":"e0131402","DOI":"10.1371\/journal.pone.0131402","article-title":"A cost-effectiveness analysis of first trimester non-invasive prenatal screening for fetal trisomies in the United States","volume":"10","author":"Walker","year":"2015","journal-title":"PLOS ONE"},{"key":"key2024062812475600_ref185-bib185","volume-title":"Systematic Review and Cost-consequence Assessment of Cell-free DNA Testing for T21, T18 and T13 in the UK: Final Report","author":"Taylor-Phillips"},{"key":"key2024062812475600_ref186-bib186","volume-title":"Vergelijking van kosten en effecten van prenatale screeningsmethoden voor Down syndroom en neuraalbuisdefecten","author":"Hoogendoorn"},{"key":"key2024062812475600_ref187-bib187","volume-title":"First and Second Trimester Prenatal Screening Update","author":"Institute of Health Economics"},{"key":"key2024062812475600_ref188-bib188","volume-title":"The Non-invasive Prenatal Test (NIPT) for Trisomy 21: Health Economic Aspects","author":"Hulstaert"},{"key":"key2024062812475600_ref189-bib189","volume-title":"Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. NG3, Feb 2015 (Appendix N.3)","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"key2024062812475600_ref190-bib190","doi-asserted-by":"crossref","first-page":"F177","DOI":"10.1136\/fn.85.3.F177","article-title":"Costs of different strategies for neonatal hearing screening: a modelling approach","volume":"85","author":"Boshuizen","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"key2024062812475600_ref191-bib191","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijporl.2011.11.004","article-title":"The economics of screening infants at risk of hearing impairment: an international analysis","volume":"76","author":"Burke","year":"2012","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"key2024062812475600_ref192-bib192","first-page":"53","article-title":"Cost effectiveness of various diagnostic strategies for detecting congenital toxoplasmosis in newborns","volume":"17","author":"Chicaiza-Becerra","year":"2013","journal-title":"Infectio"},{"key":"key2024062812475600_ref193-bib193","first-page":"Doc09","article-title":"Economic evaluation of newborn hearing screening: modelling costs and outcomes","volume":"1","author":"Hessel","year":"2003","journal-title":"Ger Med Sci"},{"key":"key2024062812475600_ref195-bib195","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archpedi.154.5.484","article-title":"A cost-effectiveness analysis of newborn hearing screening strategies","volume":"154","author":"Kemper","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key2024062812475600_ref196-bib196","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12962-019-0179-2","article-title":"Cost-effectiveness analysis of newborn pulse oximetry screening to detect critical congenital heart disease in Colombia","volume":"17","author":"Londono Trujillo","year":"2019","journal-title":"Cost Eff Resour Alloc"},{"key":"key2024062812475600_ref197-bib197","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jcf.2013.10.012","article-title":"Cost effectiveness of newborn screening for cystic fibrosis: a simulation study","volume":"13","author":"Nshimyumukiza","year":"2014","journal-title":"J Cyst Fibrosis"},{"key":"key2024062812475600_ref198-bib198","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S0266462318000181","article-title":"Ethics evaluation revealing decision-maker motives: a case of neonatal screening","volume":"34","author":"Raimond","year":"2018","journal-title":"Int J Technol Assess Health Care"},{"key":"key2024062812475600_ref199-bib199","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1472-6963-10-75","article-title":"Implementation by simulation; strategies for ultrasound screening for hip dysplasia in the Netherlands","volume":"10","author":"Ramwadhdoebe","year":"2010","journal-title":"BMC Health Serv Res"},{"key":"key2024062812475600_ref200-bib200","first-page":"1","article-title":"A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium","volume":"75","author":"Schmidt","year":"2019","journal-title":"Acta Clin Belg"},{"key":"key2024062812475600_ref201-bib201","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0969141315599421","article-title":"PAP assays in newborn screening for cystic fibrosis: a population-based cost-effectiveness study","volume":"23","author":"Seror","year":"2016","journal-title":"J Med Screen"},{"key":"key2024062812475600_ref202-bib202","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41372-020-0605-5","article-title":"Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) study","volume":"40","author":"Zupancic","year":"2020","journal-title":"J Perinatol"},{"key":"key2024062812475600_ref203-bib203","volume-title":"Newborn Screening for Medium Chain Acyl-CoA Dehydrogenase Deficiency Using Tandem Mass Spectrometry: Clinical and Cost-effectiveness","author":"Tran"},{"key":"key2024062812475600_ref204-bib204","volume-title":"Screening Newborns for Hearing","author":"Institute of Health Economics"},{"key":"key2024062812475600_ref205-bib205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000358387","article-title":"BAC chromosomal microarray for prenatal detection of chromosome anomalies in fetal ultrasound anomalies: an economic evaluation","volume":"36","author":"Hillman","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"key2024062812475600_ref206-bib206","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacr.2004.01.020","article-title":"Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome","volume":"1","author":"Kott","year":"2004","journal-title":"J Am Coll Radiol"},{"key":"key2024062812475600_ref207-bib207","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/uog.20301","article-title":"Cost-effectiveness of five prenatal screening strategies for trisomies and other unbalanced chromosomal abnormalities: model-based analysis","volume":"54","author":"Le Bras","year":"2019","journal-title":"Ultrasound in Obstet Gynecol"},{"key":"key2024062812475600_ref208-bib208","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1542\/peds.2005-2633G","article-title":"Economic evaluation of tandem mass spectrometry screening in California","volume":"117","author":"Feuchtbaum","year":"2006","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref209-bib209","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1017\/S0266462307070304","article-title":"Comparing the clinical and economic effects of clinical examination, pulse oximetry, and echocardiography in newborn screening for congenital heart defects: a probabilistic cost-effectiveness model and value of information analysis","volume":"23","author":"Griebsch","year":"2007","journal-title":"Int J Technol Assess Health Care"},{"key":"key2024062812475600_ref210-bib210","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1542\/peds.110.5.855","article-title":"Projected cost-effectiveness of statewide universal newborn hearing screening","volume":"110","author":"Keren","year":"2002","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref211-bib211","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1067\/mhn.2001.113945","article-title":"Cost and cost-effectiveness of universal screening for hearing loss in newborns","volume":"124","author":"Kezirian","year":"2001","journal-title":"Otolaryngol Head Neck Surg"},{"key":"key2024062812475600_ref212-bib212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9440","article-title":"Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis","volume":"9","author":"Knowles","year":"2005","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref213-bib213","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1542\/peds.2004-2162","article-title":"Clinical effectiveness and cost-effectiveness of the use of the thyroxine\/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program","volume":"116","author":"Lanting","year":"2005","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref214-bib214","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00431-018-3268-x","article-title":"Cost-effectiveness analysis of pulse oximetry screening for critical congenital heart defects following homebirth and early discharge","volume":"178","author":"Narayen","year":"2019","journal-title":"Eur J Pediatr"},{"key":"key2024062812475600_ref215-bib215","volume-title":"Pulse Oximetry as a Screening Test for Critical Congenital Heart Defects and Other Significant Diagnoses in Newborn Infants: A Cost Effectiveness Analysis","author":"Roberts"},{"key":"key2024062812475600_ref216-bib216","first-page":"345","article-title":"Expanded newborn screening for genetic and metabolic disorders: modeling costs and outcomes","volume":"25","author":"Hubbard","year":"2007","journal-title":"Nurs Econ"},{"key":"key2024062812475600_ref217-bib217","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pd.5605","article-title":"Cell-free DNA for Down syndrome screening in obese women: is it a cost-effective strategy?","volume":"40","author":"Hopkins","year":"2020","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref218-bib218","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/uog.19098","article-title":"Vasa previa screening strategies: decision and cost-effectiveness analysis","volume":"52","author":"Sinkey","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key2024062812475600_ref219-bib219","first-page":"6","article-title":"Pulse oximetry screening for critical congenital heart defects in Ontario, Canada: a cost-effectiveness analysis","volume":"06","author":"Mukerji","year":"2020","journal-title":"Can J Public Health"},{"key":"key2024062812475600_ref220-bib220","volume-title":"Multi Criteria Decision Analysis to Select Priority Diseases for Newborn Blood Screening","author":"De Laet"},{"key":"key2024062812475600_ref221-bib221","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1524-4733.2006.00156.x","article-title":"The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model","volume":"10","author":"Cipriano","year":"2007","journal-title":"Value Health"},{"key":"key2024062812475600_ref222-bib222","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.ijporl.2015.09.019","article-title":"Cost\u2013benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection","volume":"79","author":"Bergevin","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"key2024062812475600_ref223-bib223","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/15246090152563524","article-title":"Cost-effectiveness of prenatal screening for postpartum thyroiditis","volume":"10","author":"Bonds","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"key2024062812475600_ref224-bib224","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1210\/jc.2011-2884","article-title":"Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women","volume":"97","author":"Dosiou","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key2024062812475600_ref225-bib225","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1530\/EJE-07-0882","article-title":"Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis","volume":"158","author":"Dosiou","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key2024062812475600_ref226-bib226","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/AOG.0000000000003062","article-title":"Short-term effects and long-term cost-effectiveness of universal hepatitis C testing in prenatal care","volume":"133","author":"Tasillo","year":"2019","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref227-bib227","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13023-018-0921-4","article-title":"Economic impact of screening for X-linked adrenoleukodystrophy within a newborn blood spot screening programme","volume":"13","author":"Bessey","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"key2024062812475600_ref228-bib228","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1542\/peds.2013-0332","article-title":"Cost-effectiveness of routine screening for critical congenital heart disease in US newborns","volume":"132","author":"Peterson","year":"2013","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref229-bib229","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jval.2012.02.007","article-title":"Cost-effectiveness of expanded newborn screening in Texas","volume":"15","author":"Tiwana","year":"2012","journal-title":"Value Health"},{"key":"key2024062812475600_ref230-bib230","doi-asserted-by":"crossref","first-page":"466.e1","DOI":"10.1016\/j.ajog.2009.07.056","article-title":"Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis","volume":"201","author":"Cahill","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref231-bib231","first-page":"S236","article-title":"A new test to diagnose Down syndrome using maternal serum: at what specificity, sensitivity, and cost is it cost-effective?","volume":"204","author":"Ohno","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref232-bib232","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/sextrans-2015-052497","article-title":"Economic evaluation of universal prenatal HIV screening compared with current \u2018at risk\u2019 policy in a very low prevalence country","volume":"93","author":"Chowers","year":"2017","journal-title":"Sex Transm Infect"},{"key":"key2024062812475600_ref233-bib233","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1471-0528.2010.02621.x","article-title":"The cost-effectiveness of targeted or universal screening for vasa praevia at 18\u201320 weeks of gestation in Ontario","volume":"117","author":"Cipriano","year":"2010","journal-title":"BJOG"},{"key":"key2024062812475600_ref234-bib234","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12884-018-2114-5","article-title":"Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women","volume":"18","author":"Darlington","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"key2024062812475600_ref235-bib235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20860","article-title":"The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation","volume":"20","author":"Farrar","year":"2016","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref236-bib236","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapediatrics.2016.2016","article-title":"Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection","volume":"170","author":"Gantt","year":"2016","journal-title":"JAMA Pediatr"},{"key":"key2024062812475600_ref237-bib237","doi-asserted-by":"crossref","first-page":"S285","DOI":"10.1016\/j.ajog.2014.10.776","article-title":"Third trimester fetal growth ultrasound: a cost\u2013benefit analysis","volume":"212","author":"Hauspurg","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref238-bib238","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/AOG.0000000000002795","article-title":"Repeat screening for syphilis in the third trimester of pregnancy: a cost-effectiveness analysis","volume":"132","author":"Hersh","year":"2018","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref239-bib239","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.actatropica.2015.04.014","article-title":"Economic evaluation of chagas disease screening in Spain","volume":"148","author":"Imaz-Iglesia","year":"2015","journal-title":"Acta Trop"},{"key":"key2024062812475600_ref240-bib240","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jinf.2013.08.009","article-title":"Cost effectiveness of interferon-gamma release assay for TB screening of HIV positive pregnant women in low TB incidence countries","volume":"68","author":"Kowada","year":"2014","journal-title":"J Infect"},{"key":"key2024062812475600_ref241-bib241","doi-asserted-by":"crossref","first-page":"253.e1","DOI":"10.1016\/j.ajog.2010.01.032","article-title":"The cost-effectiveness of prenatal screening for spinal muscular atrophy","volume":"202","author":"Little","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref242-bib242","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/14767058.2013.765845","article-title":"The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel","volume":"26","author":"Marseille","year":"2013","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"key2024062812475600_ref243-bib243","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1258\/jtt.2012.120418","article-title":"The cost-effectiveness of prenatal detection for congenital heart disease using telemedicine screening","volume":"19","author":"Mistry","year":"2013","journal-title":"J Telemed Telecare"},{"key":"key2024062812475600_ref244-bib244","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajog.2004.10.600","article-title":"Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis","volume":"192","author":"Plunkett","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref245-bib245","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00125-010-1881-y","article-title":"Screening for gestational diabetes mellitus: cost\u2013utility of different screening strategies based on a woman\u2019s individual risk of disease","volume":"54","author":"Round","year":"2011","journal-title":"Diabetologia"},{"key":"key2024062812475600_ref246-bib246","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1258\/ijsa.2008.008077","article-title":"Cost-effectiveness estimates for antenatal HIV testing in the Netherlands","volume":"19","author":"Rozenbaum","year":"2008","journal-title":"Int J STD AIDS"},{"key":"key2024062812475600_ref247-bib247","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jhep.2015.05.015","article-title":"Is antenatal screening for hepatitis C virus cost-effective? A decade\u2019s experience at a London centre","volume":"63","author":"Selvapatt","year":"2015","journal-title":"J Hepatol"},{"key":"key2024062812475600_ref248-bib248","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pd.2871","article-title":"Economic assessment of screening for pre-eclampsia","volume":"32","author":"Shmueli","year":"2012","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref249-bib249","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1537-2995.2005.00645.x","article-title":"Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a","volume":"45","author":"Turner","year":"2005","journal-title":"Transfusion (Paris)"},{"key":"key2024062812475600_ref250-bib250","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1016\/j.ajog.2015.10.779","article-title":"Routine antenatal screening for depression: what are the outcomes and is it cost-effective?","volume":"214","author":"Wetzel","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref251-bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10110","article-title":"Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study","volume":"10","author":"Wu","year":"2006","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref252-bib252","doi-asserted-by":"crossref","first-page":"e0225281","DOI":"10.1371\/journal.pone.0225281","article-title":"Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: a microsimulation modeling analysis","volume":"14","author":"Zhang","year":"2019","journal-title":"PLOS ONE"},{"key":"key2024062812475600_ref253-bib253","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10198-020-01236-2","article-title":"Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands","volume":"22","author":"Eijsink","year":"2021","journal-title":"Eur J Health Econ"},{"key":"key2024062812475600_ref254-bib254","volume-title":"Antenatal Care Routine Care for the Healthy Pregnant Woman (Appendix G)","author":"National Collaborating Centre for Women\u2019s and Children\u2019s Health"},{"key":"key2024062812475600_ref255-bib255","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1542\/peds.2005-2633H","article-title":"Comprehensive cost\u2013utility analysis of newborn screening strategies","volume":"117","author":"Carroll","year":"2006","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref256-bib256","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S0266462304000984","article-title":"Cost-effectiveness of digital photographic screening for retinopathy of prematurity in the United Kingdom","volume":"20","author":"Castillo-Riquelme","year":"2004","journal-title":"Int J Technol Assess Health Care"},{"key":"key2024062812475600_ref257-bib257","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ymgme.2011.07.007","article-title":"A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID)","volume":"104","author":"Chan","year":"2011","journal-title":"Mol Genet Metab"},{"key":"key2024062812475600_ref258-bib258","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpeds.2016.01.029","article-title":"Cost-effectiveness\/cost\u2013benefit analysis of newborn screening for severe combined immune deficiency in Washington state","volume":"172","author":"Ding","year":"2016","journal-title":"J Pediatr"},{"key":"key2024062812475600_ref259-bib259","first-page":"7","article-title":"Clinical impact and cost efficacy of newborn screening for congenital adrenal hyperplasia","volume":"7","author":"Fox","year":"2020","journal-title":"J Pediatr"},{"key":"key2024062812475600_ref260-bib260","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2431-12-60","article-title":"Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France","volume":"12","author":"Hamers","year":"2012","journal-title":"BMC Pediatr"},{"key":"key2024062812475600_ref261-bib261","first-page":"203","article-title":"Hospital costs and social costs: a case study of newborn hearing screening","volume":"29","author":"Herrero","year":"2005","journal-title":"Invest Econ"},{"key":"key2024062812475600_ref262-bib262","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1067\/mpd.2002.128116","article-title":"Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel","volume":"141","author":"Insinga","year":"2002","journal-title":"J Pediatr"},{"key":"key2024062812475600_ref263-bib263","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0969141319832039","article-title":"Universal screening of newborns for biliary atresia: cost-effectiveness of alternative strategies","volume":"26","author":"Masucci","year":"2019","journal-title":"J Med Screen"},{"key":"key2024062812475600_ref264-bib264","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jpeds.2005.06.001","article-title":"Potential costs and benefits of newborn screening for severe combined immunodeficiency","volume":"147","author":"McGhee","year":"2005","journal-title":"J Pediatr"},{"key":"key2024062812475600_ref265-bib265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8120","article-title":"Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review","volume":"8","author":"Pandor","year":"2004","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref266-bib266","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3476(00)70102-8","article-title":"Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis","volume":"136","author":"Panepinto","year":"2000","journal-title":"J Pediatr"},{"key":"key2024062812475600_ref267-bib267","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1750-1172-8-167","article-title":"Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis","volume":"8","author":"Pfeil","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"key2024062812475600_ref268-bib268","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1542\/peds.2009-0605","article-title":"Projected costs, risks, and benefits of expanded newborn screening for MCADD","volume":"125","author":"Prosser","year":"2010","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref269-bib269","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1542\/peds.110.4.781","article-title":"Cost\u2013benefit analysis of universal tandem mass spectrometry for newborn screening","volume":"110","author":"Schoen","year":"2002","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref270-bib270","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0969141314542115","article-title":"Home-based screening for biliary atresia using infant stool colour cards: a large-scale prospective cohort study and cost-effectiveness analysis","volume":"21","author":"Schreiber","year":"2014","journal-title":"J Med Screen"},{"key":"key2024062812475600_ref271-bib271","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-7547-3-8","article-title":"The cost-effectiveness of neonatal screening for cystic fibrosis: an analysis of alternative scenarios using a decision model","volume":"3","author":"Simpson","year":"2005","journal-title":"Cost Eff Resour Alloc"},{"key":"key2024062812475600_ref272-bib272","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1542\/peds.2014-3399","article-title":"Cost-effectiveness analysis of a national newborn screening programme for biotinidase deficiency","volume":"136","author":"Vallejo-Torres","year":"2015","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref273-bib273","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jpeds.2007.03.013","article-title":"Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of the Netherlands","volume":"151","author":"van der Hilst","year":"2007","journal-title":"J Pediatr"},{"key":"key2024062812475600_ref274-bib274","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00431-019-03346-3","article-title":"Cost-effectiveness of newborn screening for severe combined immunodeficiency","volume":"178","author":"van der Ploeg","year":"2019","journal-title":"Eur J Pediatr"},{"key":"key2024062812475600_ref275-bib275","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jcf.2014.08.007","article-title":"Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data","volume":"14","author":"van der Ploeg","year":"2015","journal-title":"J Cyst Fibrosis"},{"key":"key2024062812475600_ref276-bib276","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1542\/peds.112.5.1005","article-title":"Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis","volume":"112","author":"Venditti","year":"2003","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref277-bib277","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000156115","article-title":"The cost effectiveness of screening newborns for congenital adrenal hyperplasia","volume":"12","author":"Yoo","year":"2009","journal-title":"Public Health Genomics"},{"key":"key2024062812475600_ref278-bib278","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0022-3476(00)90011-8","article-title":"Cost-effectiveness and implications of newborn screening for prolongation of QT interval for the prevention of sudden infant death syndrome","volume":"136","author":"Zupancic","year":"2000","journal-title":"J Pediatr"},{"key":"key2024062812475600_ref279-bib279","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/ijns6040093","article-title":"The cost-effectiveness of expanding the UK newborn bloodspot screening programme to include five additional inborn errors of metabolism","volume":"6","author":"Bessey","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"key2024062812475600_ref280-bib280","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41436-020-01038-0","article-title":"Health and economic outcomes of newborn screening for infantile-onset Pompe disease","volume":"23","author":"Richardson","year":"2020","journal-title":"Genet Med"},{"key":"key2024062812475600_ref281-bib281","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MPG.0000000000000569","article-title":"Cost-effective analysis of screening for biliary atresia with the stool color card","volume":"60","author":"Mogul","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2024062812475600_ref282-bib282","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/ijns5030028","article-title":"A cost-effectiveness analysis of newborn screening for severe combined immunodeficiency in the UK","volume":"5","author":"Bessey","year":"2019","journal-title":"Int J Neonatal Screen"},{"key":"key2024062812475600_ref283-bib283","volume-title":"Cost-effectiveness of Newborn Screening for Severe Combined Immune Deficiency","author":"Health Partners Consulting Group"},{"key":"key2024062812475600_ref284-bib284","volume-title":"\u00c9valuation de la pertinence du d\u00e9pistage n\u00e9onatal sanguin par spectrom\u00e9trie de masse en tandem de l\u2019homocystinurie classique (HCY)","author":"Turcotte"},{"key":"key2024062812475600_ref285-bib285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.AOG.0000263470.89007.e3","article-title":"First and Second Trimester Evaluation of Risk (FASTER) research consortium. First- and second-trimester evaluation of risk for Down syndrome","volume":"110","author":"Ball","year":"2007","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref286-bib286","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1016\/j.ajog.2009.10.740","article-title":"Universal antenatal screening for spinal muscular atrophy (SMA): a cost\u2013utility analysis","volume":"201","author":"Han","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref287-bib287","first-page":"68","article-title":"Economic evaluation of prenatal population screening for fragile X syndrome","volume":"8","author":"Hollingsworth","year":"2005","journal-title":"Community Genet"},{"key":"key2024062812475600_ref288-bib288","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.ajog.2005.02.052","article-title":"Cost-effectiveness analysis of prenatal population-based fragile X carrier screening","volume":"192","author":"Musci","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref289-bib289","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/pd.1498","article-title":"Sequential and contingent prenatal screening for Down syndrome","volume":"26","author":"Wald","year":"2006","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref290-bib290","first-page":"299","article-title":"Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis","volume":"111","author":"Pfeil","year":"2014","journal-title":"Mol Genet Metab"},{"key":"key2024062812475600_ref291-bib291","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.cct.2011.07.007","article-title":"Power and sample size for cost-effectiveness analysis: fFN neonatal screening","volume":"32","author":"Boyd","year":"2011","journal-title":"Contemp Clin Trials"},{"key":"key2024062812475600_ref292-bib292","doi-asserted-by":"crossref","first-page":"548.e1","DOI":"10.1016\/j.ajog.2009.12.005","article-title":"Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis","volume":"202","author":"Cahill","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref293-bib293","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1300\/J079v29n01_03","article-title":"Estimating the benefits and costs of a universal substance abuse screening and treatment referral policy for pregnant women","volume":"29","author":"Berger","year":"2002","journal-title":"J Soc Serv Res"},{"key":"key2024062812475600_ref294-bib294","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1471-0528.2007.01289.x","article-title":"Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia","volume":"114","author":"Killie","year":"2007","journal-title":"BJOG"},{"key":"key2024062812475600_ref295-bib295","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/uog.21895","article-title":"Impact of maternal obesity on fetal cardiac screening: which follow-up strategy is cost-effective?","volume":"56","author":"Bak","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key2024062812475600_ref296-bib296","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.ajog.2004.05.034","article-title":"Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy","volume":"191","author":"Baker","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref297-bib297","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11290","article-title":"Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses","volume":"11","author":"Colbourn","year":"2007","journal-title":"Health Technol Assess"},{"key":"key2024062812475600_ref298-bib298","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00125-015-3824-0","article-title":"The cost-effectiveness of screening for gestational diabetes mellitus in primary and secondary care in the Republic of Ireland","volume":"59","author":"Danyliv","year":"2016","journal-title":"Diabetologia"},{"key":"key2024062812475600_ref299-bib299","doi-asserted-by":"crossref","first-page":"546.e1","DOI":"10.1016\/j.ajog.2013.08.013","article-title":"Cost-effectiveness of transabdominal ultrasound for cervical length screening for preterm birth prevention","volume":"209","author":"Miller","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref300-bib300","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2012.06.048","article-title":"Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis","volume":"207","author":"Mission","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref301-bib301","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","article-title":"Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women","volume":"72","author":"Mone","year":"2018","journal-title":"Hypertension"},{"key":"key2024062812475600_ref302-bib302","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2337\/diacare.28.6.1482","article-title":"Screening for gestational diabetes mellitus: a decision and cost-effectiveness analysis of four screening strategies","volume":"28","author":"Nicholson","year":"2005","journal-title":"Diabetes Care"},{"key":"key2024062812475600_ref303-bib303","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1055\/s-0032-1332797","article-title":"Cost-effectiveness analysis of rubella screening strategies using electronic medical records","volume":"30","author":"Straub","year":"2013","journal-title":"Am J Perinatol"},{"key":"key2024062812475600_ref304-bib304","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajog.2004.09.134","article-title":"The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus-1 and -2 antibodies","volume":"192","author":"Thung","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref305-bib305","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/sti.2010.045559","article-title":"Projected cost-savings with herpes simplex virus screening in pregnancy: towards a new screening paradigm","volume":"87","author":"Tuite","year":"2011","journal-title":"Sex Transm Infect"},{"key":"key2024062812475600_ref306-bib306","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/1471-0528.15809","article-title":"The cost-effectiveness of universal late-pregnancy screening for macrosomia in nulliparous women: a decision analysis","volume":"126","author":"Wastlund","year":"2019","journal-title":"BJOG"},{"key":"key2024062812475600_ref307-bib307","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/dc11-1643","article-title":"Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective?","volume":"35","author":"Werner","year":"2012","journal-title":"Diabetes Care"},{"key":"key2024062812475600_ref308-bib308","first-page":"1","article-title":"Noninvasive fetal RhD blood group genotyping: a Health Technology Assessment","volume":"20","author":"Ontario","year":"2020","journal-title":"Ont Health Technol Assess Ser"},{"key":"key2024062812475600_ref309-bib309","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/AOG.0000000000001800","article-title":"Group B streptococci screening before repeat cesarean delivery: a cost-effectiveness analysis","volume":"129","author":"Albright","year":"2017","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref310-bib310","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaapos.2008.10.014","article-title":"Cost\u2013utility analysis of screening and laser treatment of retinopathy of prematurity","volume":"13","author":"Dunbar","year":"2009","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"key2024062812475600_ref311-bib311","doi-asserted-by":"crossref","first-page":"510","DOI":"10.15288\/jsad.2008.69.510","article-title":"Universal or targeted screening for fetal alcohol exposure: a cost-effectiveness analysis","volume":"69","author":"Hopkins","year":"2008","journal-title":"J Stud Alcohol Drugs"},{"key":"key2024062812475600_ref312-bib312","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/MPH.0000000000000174","article-title":"Three cost\u2013utility analyses of screening for intracranial hemorrhage in neonates with hemophilia","volume":"36","author":"Malec","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"key2024062812475600_ref313-bib313","volume-title":"Screening f\u00f6r X-bunden adrenoleukodystrofi (X-ALD)","author":"Socialstyrelsen"},{"key":"key2024062812475600_ref314-bib314","first-page":"749","article-title":"Pharmaco-economic evaluation of mandatory HIV-screening in pregnancy; a cost-efficacy analysis in Amsterdam","volume":"144","author":"Postma","year":"2000","journal-title":"Ned Tijdschr Geneeskd"},{"key":"key2024062812475600_ref315-bib315","doi-asserted-by":"crossref","first-page":"e70319","DOI":"10.1371\/journal.pone.0070319","article-title":"Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?","volume":"8","author":"Urbanus","year":"2013","journal-title":"PLOS ONE"},{"key":"key2024062812475600_ref316-bib316","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12026-014-8485-4","article-title":"An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia","volume":"60","author":"Modell","year":"2014","journal-title":"Immunol Res"},{"key":"key2024062812475600_ref317-bib317","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/eurheartj\/ehl115","article-title":"Cost-effectiveness of neonatal ECG screening for the long QT syndrome","volume":"27","author":"Quaglini","year":"2006","journal-title":"Eur Heart J"},{"key":"key2024062812475600_ref318-bib318","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/15412550500346469","article-title":"Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysis","volume":"2","author":"Shermock","year":"2005","journal-title":"COPD J Chron Obstruct Pulmon Dis"},{"key":"key2024062812475600_ref319-bib319","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.1200\/JCO.2019.37.15_suppl.10021","article-title":"Population-based cancer predisposition testing as a component of newborn screening: a cost effectiveness analysis","volume":"37","author":"Yeh","year":"2019","journal-title":"J Clin Oncol"},{"key":"key2024062812475600_ref320-bib320","unstructured":"Kanga I, Williams D, Hatchette T, MacKinnon S, Jung H, Black C, et al. Screening for Chlamydia trachomatis and Neisseria gonorrhoeae during pregnancy: Health Technology Assessment. Can Agency Drugs Technol Health 2018. (CADTH health technology assessment report; no. 148)."},{"key":"key2024062812475600_ref321-bib321","first-page":"16","article-title":"Detection of fetal cardiac anomalies: is increasing the number of cardiac views cost-effective?","volume":"16","author":"Bak","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key2024062812475600_ref322-bib322","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.endonu.2015.03.007","article-title":"Cost-effectiveness analysis of universal screening for thyroid disease in pregnant women in Spain","volume":"62","author":"Donnay Candil","year":"2015","journal-title":"Endocrinol Nutr"},{"key":"key2024062812475600_ref323-bib323","first-page":"S214","article-title":"Routine antenatal testing for pregnancies at 40 weeks gestation: a cost-effectiveness analysis","volume":"210","author":"Dorius","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref324-bib324","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2045-4015-2-6","article-title":"Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost\u2013utility analysis","volume":"2","author":"Ginsberg","year":"2013","journal-title":"Isr J Health Policy Res"},{"key":"key2024062812475600_ref325-bib325","first-page":"693","article-title":"Routine pre-cesarean Staphylococcus aureus screening and decolonization: a cost-effectiveness analysis","volume":"17","author":"Lee","year":"2011","journal-title":"Am J Manag Care"},{"key":"key2024062812475600_ref326-bib326","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/pd.1322","article-title":"Should all pregnant diabetic women undergo a fetal echocardiography? A cost-effectiveness analysis comparing four screening strategies","volume":"26","author":"Odibo","year":"2006","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref327-bib327","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/20477724.2016.1258162","article-title":"Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women","volume":"110","author":"Rours","year":"2016","journal-title":"Pathog Glob Health"},{"key":"key2024062812475600_ref328-bib328","doi-asserted-by":"crossref","first-page":"6024698","DOI":"10.1155\/2018\/6024698","article-title":"Universal rapid human immunodeficiency virus screening at delivery: a cost-effectiveness analysis","volume":"2018","author":"Scott","year":"2018","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key2024062812475600_ref329-bib329","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.actatropica.2011.02.012","article-title":"Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area","volume":"118","author":"Sicuri","year":"2011","journal-title":"Acta Trop"},{"key":"key2024062812475600_ref330-bib330","doi-asserted-by":"crossref","first-page":"934698","DOI":"10.1155\/2009\/934698","article-title":"Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization","volume":"2009","author":"Turrentine","year":"2009","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key2024062812475600_ref332-bib332","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/pd.5803","article-title":"Isolated echogenic intracardiac foci and the role of cell-free fetal DNA: a cost-effectiveness analysis","volume":"40","author":"Hacker","year":"2020","journal-title":"Prenat Diagn"},{"key":"key2024062812475600_ref333-bib333","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1055\/s-0038-1676495","article-title":"Cytomegalovirus screening in pregnancy: a cost-effectiveness and threshold analysis","volume":"36","author":"Albright","year":"2019","journal-title":"Am J Perinatol"},{"key":"key2024062812475600_ref334-bib334","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/1471-0528.13801","article-title":"Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis","volume":"123","author":"Neovius","year":"2016","journal-title":"BJOG"},{"key":"key2024062812475600_ref335-bib335","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12879-017-2248-5","article-title":"Cost\u2013benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States","volume":"17","author":"Ditkowsky","year":"2017","journal-title":"BMC Infect Dis"},{"key":"key2024062812475600_ref336-bib336","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1067\/S0002-9378(03)00717-8","article-title":"Prenatal cystic fibrosis screening in Mexican Americans: an economic analysis","volume":"189","author":"Doyle","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref337-bib337","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/AOG.0b013e31824b1461","article-title":"Cost and effectiveness of intrapartum group B streptococcus polymerase chain reaction screening for term deliveries","volume":"119","author":"El Helali","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key2024062812475600_ref338-bib338","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0412.2004.00262.x","article-title":"Cost-effectiveness of screening and treatment for bacterial vaginosis in early pregnancy among women at low risk for preterm birth","volume":"83","author":"Kekki","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key2024062812475600_ref339-bib339","first-page":"2350","article-title":"Screening for asymptomatic infection with Chlamydia trachomatis in pregnancy; favourable cost-effectiveness if prevalence is 3% or more","volume":"144","author":"Postma","year":"2000","journal-title":"Ned Tijdschr Geneeskd"},{"key":"key2024062812475600_ref340-bib340","doi-asserted-by":"crossref","first-page":"e0221709","DOI":"10.1371\/journal.pone.0221709","article-title":"The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis","volume":"14","author":"Binquet","year":"2019","journal-title":"PLOS ONE"},{"key":"key2024062812475600_ref341-bib341","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1542\/peds.110.3.471","article-title":"Perinatal screening for group B streptococci: cost\u2013benefit analysis of rapid polymerase chain reaction","volume":"110","author":"Haberland","year":"2002","journal-title":"Pediatrics"},{"key":"key2024062812475600_ref342-bib342","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1080\/14767058.2017.1369041","article-title":"Intrapartum test for detection of group B streptococcus colonization during labor","volume":"31","author":"Picchiassi","year":"2018","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"key2024062812475600_ref343-bib343","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1440-1754.2005.00725.x","article-title":"Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism","volume":"41","author":"Geelhoed","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"key2024062812475600_ref344-bib344","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1651-2227.2005.tb02050.x","article-title":"Screening for congenital cataracts: a cost-consequence analysis of eye examination at maternity wards in comparison to well-baby clinics","volume":"94","author":"Magnusson","year":"2005","journal-title":"Acta Paediatr"},{"key":"key2024062812475600_ref345-bib345","doi-asserted-by":"crossref","first-page":"e1333","DOI":"10.1371\/journal.pntd.0001333","article-title":"Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model","volume":"5","author":"Stillwaggon","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key2024062812475600_ref346-bib346","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/adc.88.9.760","article-title":"Efficiency of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom","volume":"88","author":"Brown","year":"2003","journal-title":"Arch Dis Child"},{"key":"key2024062812475600_ref347-bib347","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2003.10.192","article-title":"Prenatal Down syndrome screening: a cost analysis of different strategies","volume":"189","author":"Brancazio","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"key2024062812475600_ref348-bib348","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1080\/10810730.2010.522226","article-title":"Parental information seeking following a positive newborn screening for cystic fibrosis","volume":"15","author":"Dillard","year":"2010","journal-title":"J Health Commun"},{"key":"key2024062812475600_ref349-bib349","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jme.2010.039206","article-title":"Parents\u2019 experiences of newborn screening for genetic susceptibility to type 1 diabetes","volume":"37","author":"Kerruish","year":"2011","journal-title":"J Med Ethics"},{"key":"key2024062812475600_ref350-bib350","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2015.73","article-title":"Parents\u2019 experiences 12 years after newborn screening for genetic susceptibility to type 1 diabetes and their attitudes to whole-genome sequencing in newborns","volume":"18","author":"Kerruish","year":"2016","journal-title":"Genet Med"},{"key":"key2024062812475600_ref351-bib351","first-page":"20","article-title":"Cystic fibrosis diagnosis: impact on mothers of affected Australian children","volume":"12","author":"Priddis","year":"2009","journal-title":"Neonatal Paediatr Child Health Nurs"},{"key":"key2024062812475600_ref352-bib352","first-page":"3","article-title":"Paternal experiences of their children\u2019s diagnosis of Cystic Fibrosis following newborn screening diagnosis","volume":"13","author":"Priddis","year":"2010","journal-title":"Neonatal Paediatr Child Health Nurs"},{"key":"key2024062812475600_ref353-bib353","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/gim.2011.5","article-title":"The impact of false-positive newborn screening results on families: a qualitative study","volume":"14","author":"Schmidt","year":"2012","journal-title":"Genet Med"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2045448","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/PYTK6591\/PYTK6591.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2045448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T07:27:47Z","timestamp":1719559667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/PYTK6591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":349,"alternative-id":["10.3310\/PYTK6591"],"URL":"https:\/\/doi.org\/10.3310\/pytk6591","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"01-2020","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"04-2022","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"12-2022","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}